240 related articles for article (PubMed ID: 21705685)
41. Overexpression of 15-lipoxygenase-1 in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via downregulation of vascular endothelial growth factor-A expression.
Li Z; He T; Du K; Xing YQ; Yan Y; Chen Z; Zhang H; Shen Y
Mol Vis; 2012; 18():2847-59. PubMed ID: 23233787
[TBL] [Abstract][Full Text] [Related]
42. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
[TBL] [Abstract][Full Text] [Related]
43. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
McGuire PG; Jones TR; Talarico N; Warren E; Das A
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081
[TBL] [Abstract][Full Text] [Related]
44. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
45. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
Kociok N; Krohne TU; Poulaki V; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
[TBL] [Abstract][Full Text] [Related]
46. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
47. Caveolin-1 expression regulates blood-retinal barrier permeability and retinal neovascularization in oxygen-induced retinopathy.
Tian XF; Xia XB; Xu HZ; Xiong SQ; Jiang J
Clin Exp Ophthalmol; 2012; 40(1):e58-66. PubMed ID: 21794046
[TBL] [Abstract][Full Text] [Related]
48. Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina.
Stitt AW; Graham D; Gardiner TA
Mol Vis; 2004 Jun; 10():432-8. PubMed ID: 15235573
[TBL] [Abstract][Full Text] [Related]
49. A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.
Deliyanti D; Lee JY; Petratos S; Meyer CJ; Ward KW; Wilkinson-Berka JL; de Haan JB
Clin Sci (Lond); 2016 Aug; 130(15):1375-87. PubMed ID: 27005782
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
[TBL] [Abstract][Full Text] [Related]
51. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.
Hua J; Guerin KI; Chen J; Michán S; Stahl A; Krah NM; Seaward MR; Dennison RJ; Juan AM; Hatton CJ; Sapieha P; Sinclair DA; Smith LE
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2809-16. PubMed ID: 21282584
[TBL] [Abstract][Full Text] [Related]
52. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy.
Lee YM; Lee YR; Kim CS; Jo K; Sohn E; Kim JS; Kim J
Int J Mol Sci; 2015 Dec; 16(12):29900-10. PubMed ID: 26694358
[TBL] [Abstract][Full Text] [Related]
53. Increased retinal neovascularization in Fas ligand-deficient mice.
Davies MH; Eubanks JP; Powers MR
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
[TBL] [Abstract][Full Text] [Related]
54. Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy.
Vessey KA; Wilkinson-Berka JL; Fletcher EL
J Comp Neurol; 2011 Feb; 519(3):506-27. PubMed ID: 21192081
[TBL] [Abstract][Full Text] [Related]
55. Suppression of Retinal Neovascularization by Anti-CCR3 Treatment in an Oxygen-Induced Retinopathy Model in Mice.
Hirahara S; Nozaki M; Ohbayashi M; Hasegawa N; Ozone D; Ogura Y
Ophthalmic Res; 2017; 58(1):56-66. PubMed ID: 28376500
[TBL] [Abstract][Full Text] [Related]
56. Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.
Zhang S; Li H; Li B; Zhong D; Gu X; Tang L; Wang Y; Wang C; Zhou R; Li Y; He Y; Chen M; Huo Y; Liu XL; Chen JF
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8108-19. PubMed ID: 26720463
[TBL] [Abstract][Full Text] [Related]
57. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
[TBL] [Abstract][Full Text] [Related]
58. Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.
Jiang Y; Wang H; Culp D; Yang Z; Fotheringham L; Flannery J; Hammond S; Kafri T; Hartnett ME
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):824-31. PubMed ID: 24425851
[TBL] [Abstract][Full Text] [Related]
59. The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity.
Hackett SF; Seidel C; Abraham S; Chadha R; Fortmann SD; Campochiaro PA; Cooke JP
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1296-1303. PubMed ID: 28241318
[TBL] [Abstract][Full Text] [Related]
60. Supplemental oxygen therapy. Basis for noninvasive treatment of retinopathy of prematurity.
Tailoi CL; Gock B; Stone J
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1215-30. PubMed ID: 7775099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]